Capillary Technologies India Limited (NSE:CAPILLARY)
India · Delayed Price · Currency is INR 562.15
-15.40 (-2.67%)
At close: Feb 12, 2026
NSE:CAPILLARY Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 6,953 | 5,983 | 5,251 | 3,227 | 2,231 | 1,709 |
Other Revenue | 23.73 | 23.73 | -2,024 | - | - | 49.23 |
| 6,977 | 6,006 | 3,227 | 3,227 | 2,231 | 1,758 | |
Revenue Growth (YoY) | - | 86.11% | 0.02% | 44.66% | 26.86% | 5.85% |
Cost of Revenue | 4,500 | 3,877 | 4,072 | 2,814 | 1,870 | 1,229 |
Gross Profit | 2,477 | 2,129 | -844.95 | 412.73 | 360.22 | 529.37 |
Selling, General & Admin | 1,087 | 994.93 | 873.15 | 418.22 | 383.14 | 219.13 |
Other Operating Expenses | 517.7 | 461.23 | 422.63 | 598.12 | 480.55 | 379.9 |
Operating Expenses | 2,324 | 2,057 | 1,856 | 1,412 | 1,151 | 776.9 |
Operating Income | 153.15 | 72.08 | -2,701 | -999.29 | -790.62 | -247.53 |
Interest Expense | -45.66 | -63.62 | -161.84 | -102.98 | -44.04 | -17 |
Interest & Investment Income | 29.68 | 29.68 | 276.59 | 15.25 | 5.1 | 12.91 |
Currency Exchange Gain (Loss) | 18.1 | 18.1 | 1,805 | 25.4 | - | -4.93 |
Other Non Operating Income (Expenses) | -0.12 | -0.42 | 1.34 | 20.47 | -41.53 | 5.19 |
EBT Excluding Unusual Items | 155.15 | 55.82 | -780.25 | -1,041 | -871.09 | -251.36 |
Gain (Loss) on Sale of Investments | 50.13 | 50.13 | 27.14 | - | - | - |
Gain (Loss) on Sale of Assets | 0.62 | 0.62 | 0.51 | 0.06 | - | 0.55 |
Asset Writedown | 0.25 | 0.25 | - | - | - | -2.29 |
Other Unusual Items | - | - | - | 113.82 | -160.07 | 27.9 |
Pretax Income | 206.15 | 106.82 | -752.6 | -927.27 | -1,031 | -225.2 |
Income Tax Expense | -14.55 | -34.72 | -69.09 | -50.08 | -22.75 | 3.1 |
Earnings From Continuing Operations | 220.7 | 141.54 | -683.51 | -877.19 | -1,008 | -228.3 |
Earnings From Discontinued Operations | -32.04 | -8.74 | 89.73 | - | - | - |
Net Income | 188.66 | 132.8 | -593.78 | -877.19 | -1,008 | -228.3 |
Net Income to Common | 188.66 | 132.8 | -593.78 | -877.19 | -1,008 | -228.3 |
Shares Outstanding (Basic) | 74 | 73 | 56 | 50 | 49 | 48 |
Shares Outstanding (Diluted) | 74 | 74 | 56 | 50 | 49 | 48 |
Shares Change (YoY) | 1.49% | 31.56% | 12.45% | 2.33% | 2.24% | 0.01% |
EPS (Basic) | 2.55 | 1.81 | -10.55 | -17.53 | -20.62 | -4.77 |
EPS (Diluted) | 2.53 | 1.79 | -10.56 | -17.53 | -20.62 | -4.77 |
Free Cash Flow | - | -936.57 | 602.03 | -482.58 | -101.71 | -113.14 |
Free Cash Flow Per Share | - | -12.65 | 10.70 | -9.64 | -2.08 | -2.37 |
Gross Margin | 35.50% | 35.45% | -26.18% | 12.79% | 16.15% | 30.11% |
Operating Margin | 2.20% | 1.20% | -83.70% | -30.97% | -35.44% | -14.08% |
Profit Margin | 2.70% | 2.21% | -18.40% | -27.18% | -45.21% | -12.98% |
Free Cash Flow Margin | - | -15.59% | 18.65% | -14.95% | -4.56% | -6.43% |
EBITDA | 805.04 | 660.41 | -2,142 | -626.42 | -533.15 | -237.51 |
EBITDA Margin | 11.54% | 11.00% | -66.38% | -19.41% | -23.90% | -13.51% |
D&A For EBITDA | 651.89 | 588.33 | 559.16 | 372.87 | 257.47 | 10.02 |
EBIT | 153.15 | 72.08 | -2,701 | -999.29 | -790.62 | -247.53 |
EBIT Margin | 2.20% | 1.20% | -83.70% | -30.97% | -35.44% | -14.08% |
Revenue as Reported | 7,049 | 6,119 | 5,354 | 3,336 | 2,244 | 1,810 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.